Cargando…
Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing
Drug-induced liver injury (DILI) is one of the leading causes of clinical trial failures and high drug attrition rates. Currently, the commonly used hepatocyte models include primary human hepatocytes (PHHs), animal models, and hepatic cell lines. However, these models have disadvantages that includ...
Autores principales: | Jin, Meixian, Yi, Xiao, Liao, Wei, Chen, Qi, Yang, Wanren, Li, Yang, Li, Shao, Gao, Yi, Peng, Qing, Zhou, Shuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836452/ https://www.ncbi.nlm.nih.gov/pubmed/33494782 http://dx.doi.org/10.1186/s13287-021-02152-9 |
Ejemplares similares
-
Establishing an hTERT-driven immortalized umbilical cord-derived mesenchymal stem cell line and its therapeutic application in mice with liver failure
por: Chen, Qi, et al.
Publicado: (2023) -
Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
por: Choudhury, Yukti, et al.
Publicado: (2017) -
Corrigendum: Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
por: Choudhury, Yukti, et al.
Publicado: (2017) -
Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening
por: Wang, Zhenyu, et al.
Publicado: (2019) -
Application of 3D Hepatic Plate-Like Liver Model for Statin-Induced Hepatotoxicity Evaluation
por: Xu, Jiecheng, et al.
Publicado: (2022)